CommentaryA day in the life of the Bcl-2 protein: Does the turnover rate of Bcl-2 serve as a biological clock for cellular lifespan regulation?
References (24)
Bcl-2: prevention of apoptosis as a mechanism of drug resistance
Hematol. Oncol. Clin. N. Am.
(1995)- et al.
BCL-2 proto-oncogene expression in normal and neoplastic human myeloid cells
Blood
(1992) - et al.
High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
Blood
(1993) - et al.
BCL-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
Blood
(1993) - et al.
Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of Bcl-2 protein
Blood
(1993) - et al.
Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells
Blood
(1994) - et al.
Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity
Cell
(1995) - et al.
Involvement of the BCL-2 gene in human follicular lymphoma
Science
(1985) - et al.
BCL-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Nature
(1988) Bcl-2 and the regulation of programmed cell death
J. Cell Biol.
(1994)
Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
Antisense-mediated inhibition of BCL-2 proto-oncogene expression and leukemic cell growth: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
Cancer Res.
(1990)
Cited by (0)
Copyright © 1996 Published by Elsevier Ltd.